Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)
Titel:
Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)
Auteur:
Saiag, P. Gutzmer, R. Ascierto, P.A. Maio, M. Grob, J.-J. Murawa, P. Dreno, B. Ross, M. Weber, J. Hauschild, A. Rutkowski, P. Testori, A. Levchenko, E. Enk, A. Misery, L. Vanden Abeele, C. Vojtek, I. Peeters, O. Brichard, V.G. Therasse, P.